--- title: How Particulate Control Can Save or Destroy Your Next Launch description: The recent destruction of millions of vaccine doses is one very prominent example of how crucial particulate control in your packaging is for your launch. image: https://www.oliverhcp.com/hubfs/Laboratory%20Pipette%20with%20Blue%20Liquid%20Over%20Glass%20Test%20Tubes..jpeg --- [Skip to Main Content](https://www.oliverhcp.com/news-and-resources/packtalk/how-particulate-control-can-save-or-destroy-your-next-launch#main-content) Language ![](https://www.oliverhcp.com/hubfs/down_arrow.svg) English ESPAÑOL DEUTSCH FRANÇAIS 日本語 한국어 中文 - [PackTalk ](https://www.oliverhcp.com/packtalk/) - [ISO Certifications & Product Documents ](https://www.oliverhcp.com/iso-certifications-and-product-documents) [![Oliver_Logo_4clr_RGB_NoTag 1](https://www.oliverhcp.com/hubfs/Oliver_Logo_4clr_RGB_NoTag%201.svg "Oliver_Logo_4clr_RGB_NoTag 1")](https://oliverhcp.com) Toggle Menu Search Site Search Site Search [ Contact Us ](https://www.oliverhcp.com/contact) Phone Close **Website Settings** - No Animations [![](https://www.oliverhcp.com/hubfs/Oliver-logo-half.svg) ](https://www.oliverhcp.com/) [![](https://www.oliverhcp.com/hubfs/phone.svg) 833.465.4837](tel:833.465.4837) Language ![](https://www.oliverhcp.com/hubfs/down_arrow.svg) ENGLISH 中文 ESPAÑOL DEUTSCH FRANÇAIS 日本語 한국어 [PackTalk](https://www.oliverhcp.com/packtalk/) SEARCH![](https://www.oliverhcp.com/hubfs/icon-search.svg) #### Expanded Stock Pouch Program ![](https://www.oliverhcp.com/hubfs/43.png) Expedited shipping from a partner you trust, now with more pouch options in a variety of sizes and materials. Don't let long lead times hold you back. Let Oliver help. [Learn More](https://www.oliverhcp.com/stockpouchprogram) [![logo-pack-talk-2](https://www.oliverhcp.com/hubfs/logo-pack-talk-2.svg) ](https://www.oliverhcp.com/packtalk/) # How Particulate Control Can Save or Destroy Your Next Launch Oliver Healthcare Packaging Published on: 07/21/2021 Share:  [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/sharing/share-offsite/?url=https://www.oliverhcp.com/news-and-resources/packtalk/how-particulate-control-can-save-or-destroy-your-next-launch) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/sharer/sharer.php?u=https://www.oliverhcp.com/news-and-resources/packtalk/how-particulate-control-can-save-or-destroy-your-next-launch) [![](https://www.oliverhcp.com/hubfs/Email%20Icon.svg)](mailto:?subject=I%20wanted%20to%20share%20this%20great%20article&body=The%20article%20I%20wanted%20to%20share%20-%20https://www.oliverhcp.com/news-and-resources/packtalk/how-particulate-control-can-save-or-destroy-your-next-launch) In the midst of a pandemic raging across the world, pharmaceutical companies are more and more alerted to the dangers and risks of drug product contamination. The recent FDA-ordered destruction of [60 million vaccine doses](https://healthpolicy-watch.news/fda-orders-some-60-million-vaccines-made-by-emergent-to-be-destroyed/) is one very prominent example. One source of contamination is particulate generation. Pharma companies are researching [smarter control of particulate](https://www.epmmagazine.com/pharmaceutical-industry-insights/the-prefillable-solution-%E2%80%94-how-packaging-solutions-can-help-/) in hopes to specifically reduce or eliminate particulate in injectable products. Particulates can be of two types: - Visible particulates are greater than or equal to 100 microns - **Sub-visible** particulates are less than or equal to 100 microns. Sources of particulates can be inherent, intrinsic, or extrinsic. They may be introduced as part of the process itself or from external sources such as packaging materials. Particulate generation can also impact the biological response from a patient. For example, presence of particulates in the vascular system can cause blockage, emboli, or accumulation or chronic damage to organs. In the case of extravascular particulates, it may impact the immune response in patients and may cause tissue damage. ![Laboratory Pipette with Blue Liquid Over Glass Test Tubes.](https://www.oliverhcp.com/hubfs/Laboratory%20Pipette%20with%20Blue%20Liquid%20Over%20Glass%20Test%20Tubes..jpeg?quality=low) As expected, there are several regulatory standards that specify the requirements for control of particulate in pharmaceutical applications. The list of requirements is long. The main standard to evaluate is [ISO 11040-7](https://www.iso.org/standard/59937.html), Prefilled syringes - Part 7: Packaging systems for sterilized sub-assembled syringes ready for filling. We previously covered that standard in more detail [here](https://www.oliverhcp.com/news-and-resources/packtalk/the-411-on-iso-11040-7). Other standards, such as [USP788 ](https://www.uspnf.com/sites/default/files/usp_pdf/EN/USPNF/revisionGeneralChapter788.pdf)(Injections) and USP789 (Ophthalmic), specify the number and the size of allowable particulates within a drug container. Particulate is typically counted through two methods, a Light Obscuration Test or a Microscopic Test. During the production process for prefillable syringes, the syringe tub is moved into an isolator or controlled environment. The lid is peeled and removed from the syringe tub, usually by a [robotic process](https://www.youtube.com/watch?v=8GSdRew4OxY). It must be stressed that particulate generation is minimized during this peeling process. The right material selection is important here. Coating on the lidding material can help lessen particulate from peeling, as described in our [technical evaluation](https://www.oliverhcp.com/news-and-resources/packtalk/new-independent-study)  of lidding removal. Maintaining a highly sterile environment during the entire drug delivery process is of critical importance. This includes the selection of an uncompromising sterile barrier system. Since the entire drug process is so long (taking years between development and final launch), pharma companies rely on their partner network to interpret regulatory procedures and operationalise standards in the manufacturing process. The tragedy of the vaccine destruction story is a big reminder of how much is at stake. Share:  [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/sharing/share-offsite/?url=https://www.oliverhcp.com/news-and-resources/packtalk/how-particulate-control-can-save-or-destroy-your-next-launch) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/sharer/sharer.php?u=https://www.oliverhcp.com/news-and-resources/packtalk/how-particulate-control-can-save-or-destroy-your-next-launch) [![](https://www.oliverhcp.com/hubfs/Email%20Icon.svg)](mailto:?subject=I%20wanted%20to%20share%20this%20great%20article&body=The%20article%20I%20wanted%20to%20share%20-%20https://www.oliverhcp.com/news-and-resources/packtalk/how-particulate-control-can-save-or-destroy-your-next-launch) ## Stay up to date with PackTalk! FOLLOW US: [![](https://www.oliverhcp.com/hubfs/LinkedIn%20Icon.svg)](https://www.linkedin.com/company/oliverhealthcarepackaging) [![](https://www.oliverhcp.com/hubfs/FB%20Icon.svg)](https://www.facebook.com/oliverhcp/) [![](https://www.oliverhcp.com/hubfs/Content%20Hub/youtube.svg)](https://www.youtube.com/channel/UCzbJZ9TG2QK46F_EV-szUMg) ## Recently Published Articles [![](https://www.oliverhcp.com/hubfs/seal%20creep%20blog.png) ](https://www.oliverhcp.com/news-and-resources/packtalk/investigating-seal-creep-looking-beyond-the-packaging) ### [Investigating Seal Creep: Looking Beyond the Packaging](https://www.oliverhcp.com/news-and-resources/packtalk/investigating-seal-creep-looking-beyond-the-packaging) Lee Hyland ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Education Regulations and Standards  — 2 minute read [![](https://www.oliverhcp.com/hubfs/megan%20blog%206-23.jpg) ](https://www.oliverhcp.com/news-and-resources/packtalk/preventing-packaging-failures-with-hdpe-cards) ### [Preventing Packaging Failures with HDPE Cards](https://www.oliverhcp.com/news-and-resources/packtalk/preventing-packaging-failures-with-hdpe-cards) Christian Packard ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Regulations and Standards  — 2 minute read [![](https://www.oliverhcp.com/hubfs/Blog%20Image%20%286%29.png) ](https://www.oliverhcp.com/news-and-resources/packtalk/australias-unique-device-identification-framework) ### [Australia’s Unique Device Identification Framework](https://www.oliverhcp.com/news-and-resources/packtalk/australias-unique-device-identification-framework) Beryl Choo ![](https://www.oliverhcp.com/hubfs/Content%20Hub/icon-mt-blog-article.svg) Regulations and Standards Medical Device  — 3 minute read ## Contact Us ![](https://www.oliverhcp.com/hubfs/icon-mail-alt.svg) CONTACT US CHAT ![](https://dc.ads.linkedin.com/collect/?pid=94507&fmt=gif)